Products

ZOSTAVAX^TM

Disclaimer

Original Notice of Compliance (NoC)

22 August 2008

Therapeutic / Pharmacological Classification

Vaccine for Active Immunization against herpes zoster (shingles)

Product Monograph / Prescribing Information / Product Information

Date of Approval: February 9, 2010 (10,06-a_136641)
File name: ZOSTAVAX_1006-a_136641_E.pdf
File size: 392 KB

CONSUMER INFORMATION

Date of Approval: February 9, 2010 (10,06-a_136641)
File name: ZOSTAVAX_1006-a_136641_CI_E.pdf
File size: 163 KB

Web site

www.zostavax.ca

This file is presented in PDF format. This software is available at no charge through the Adobe Web site. Get Adobe Reader

DISCLAIMER
The contents of this site, including but not limited to Merck Frosst product information and product monographs, are for informational purposes only and are intended solely for residents of Canada, and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician, pharmacist or other qualified health care provider with any questions you may have regarding a medical condition.

ZOSTAVAX™ is a Trademark of Merck & Co., Inc. Used under license

Printer friendly

Email a friend

This site is for residents of Canada. / This site was updated on August 25, 2010.

ZOSTAVAXTM